Literature DB >> 9686439

Novel p53 tumour suppressor mutations in cases of spindle cell sarcoma, pleomorphic sarcoma and fibrosarcoma in cats.

B Mayr1, M Reifinger, K Alton, G Schaffner.   

Abstract

Twenty feline neoplasms were sequenced in the region from exons 5 to 8 for the presence of tumour suppressor gene p53 mutations. In a spindle cell sarcoma of the bladder, a missense mutation (codon 164 AAG-->GAG, lysine-->glutamic acid) in exon 5 was detected. In a pleomorphic sarcoma, a 23 bp deletion involving the splicing junction between intron 5 and exon 6 was observed. In a fibrosarcoma, a 6 bp deletion of p53 covering 2 bp of exon 7 and 4 bp of intron 7, including the splicing junction, was found. The study demonstrates three new p53 mutations in different types of sarcomas in cats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686439     DOI: 10.1023/a:1006091215330

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  13 in total

Review 1.  p53 function and dysfunction.

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

2.  An efficient salt-chloroform extraction of DNA from blood and tissues.

Authors:  R Müllenbach; P J Lagoda; C Welter
Journal:  Trends Genet       Date:  1989-12       Impact factor: 11.639

3.  Sequence of an exon of the feline p53 gene--mutation in a lymphosarcoma.

Authors:  B Mayr; U Heczko; K Schellander; W Schleger; M Reifinger
Journal:  Br Vet J       Date:  1993 Jul-Aug

4.  Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation.

Authors:  M Hollstein; B Shomer; M Greenblatt; T Soussi; E Hovig; R Montesano; C C Harris
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

5.  Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.

Authors:  J A Roth; D Nguyen; D D Lawrence; B L Kemp; C H Carrasco; D Z Ferson; W K Hong; R Komaki; J J Lee; J C Nesbitt; K M Pisters; J B Putnam; R Schea; D M Shin; G L Walsh; M M Dolormente; C I Han; F D Martin; N Yen; K Xu; L C Stephens; T J McDonnell; T Mukhopadhyay; D Cai
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

Review 6.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

Review 7.  Gene therapy for head and neck cancer.

Authors:  R L Breau; G L Clayman
Journal:  Curr Opin Oncol       Date:  1996-05       Impact factor: 3.645

8.  Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses.

Authors:  E M De Vries; D O Ricke; T N De Vries; A Hartmann; H Blaszyk; D Liao; T Soussi; J S Kovach; S S Sommer
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

9.  Cloning of feline p53 tumor-suppressor gene and its aberration in hematopoietic tumors.

Authors:  M Okuda; A Umeda; T Sakai; T Ohashi; Y Momoi; H Y Youn; T Watari; R Goitsuka; H Tsujimoto; A Hasegawa
Journal:  Int J Cancer       Date:  1994-08-15       Impact factor: 7.396

10.  Mutations in tumour suppressor gene p53 in two feline fibrosarcomas.

Authors:  B Mayr; G Schaffner; R Kurzbauer; A Schneider; M Reifinger; G Loupal
Journal:  Br Vet J       Date:  1995 Nov-Dec
View more
  2 in total

1.  Sequence variants and haplotype analysis of cat ERBB2 gene: a survey on spontaneous cat mammary neoplastic and non-neoplastic lesions.

Authors:  Sara Santos; Estela Bastos; Cláudia S Baptista; Daniela Sá; Christophe Caloustian; Henrique Guedes-Pinto; Fátima Gärtner; Ivo G Gut; Raquel Chaves
Journal:  Int J Mol Sci       Date:  2012-03-02       Impact factor: 6.208

2.  Biological indicators of chemoresistance: an ex vivo analysis of γH2AX and p53 expression in feline injection-site sarcomas.

Authors:  Yike Bing; Zacharie Wund; Tina Abratte; Lucia Borlle; Susie Kang; Teresa Southard; Kelly R Hume
Journal:  Cancer Cell Int       Date:  2018-11-22       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.